News
“The Healthcare Distribution Alliance and our nearly 40 healthcare distributor members are committed to working with Secretary Kennedy and the Trump administration to improve access to medications for all Americans while maintaining an efficient and reliable pharmaceutical supply chain. As logistics experts and a critical connection point between 1,200 manufacturers and approximately 330,000 sites of care, pharmaceutical distributors deliver 10 million medicines and healthcare products each day.
“HDA and our members work closely with HHS, as well as the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS) and the Administration for Strategic Preparedness and Response (ASPR), on a range of issues and shared priorities. HDA will continue to be a thought leader to HHS and its agencies as we collectively address Drug Supply Chain Security Act implementation, healthcare emergency planning and response efforts, the prevention of drug shortages, and the effective implementation of the Medicare Drug Price Negotiation Program, among other priorities. Working collaboratively, we will move closer to achieving our common goal of advancing the health and well-being of all Americans.”
HDA Statement on the Confirmation of Robert F. Kennedy, Jr. As HHS Secretary
February 13, 2025 HDA released a statement on the confirmation of Robert F. Kennedy, Jr., to lead the U.S. Department of Health and Human Services:“The Healthcare Distribution Alliance and our nearly 40 healthcare distributor members are committed to working with Secretary Kennedy and the Trump administration to improve access to medications for all Americans while maintaining an efficient and reliable pharmaceutical supply chain. As logistics experts and a critical connection point between 1,200 manufacturers and approximately 330,000 sites of care, pharmaceutical distributors deliver 10 million medicines and healthcare products each day.
“HDA and our members work closely with HHS, as well as the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS) and the Administration for Strategic Preparedness and Response (ASPR), on a range of issues and shared priorities. HDA will continue to be a thought leader to HHS and its agencies as we collectively address Drug Supply Chain Security Act implementation, healthcare emergency planning and response efforts, the prevention of drug shortages, and the effective implementation of the Medicare Drug Price Negotiation Program, among other priorities. Working collaboratively, we will move closer to achieving our common goal of advancing the health and well-being of all Americans.”
About HDA
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.